VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1508220
Sex: F
Age:
State: OH

Vax Date: 03/12/2021
Onset Date: 03/12/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left arm, left leg, left groin, left side of neck , face and chin tingling/ pins and needles; lips and under tongue tingling; Neck felt like it was on fire; Painful; This is a spontaneous report from a contactable nurse. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the arm left on 12Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to shellfish and avocado. Concomitant medications include prenatal medication, birth control medication, plantago ovata (METAMUCIL), ibuprofen (MOTRIN) and paracetamol (TYLENOL). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021, 30 mins after the vaccine the patient felt left arm, left leg, left groin, left side of neck and the face tingling. Then 45 mins after the vaccine the patient's neck felt like it was on fire. It was reported that the last 24 days (at the time of this report) the patient still had burning, tingling in neck, face, chin, lips and under tongue in mouth. It happened almost every day sometimes twice a day and felt like painful, burns and also felt like pins and needles. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events left arm, left leg, left groin, left side of neck, face, chin, lips and under tongue was tingling, felt like pins and needles, neck felt like it was on fire and painful was recovered with sequelae on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: Metamucil; Motrin; TYLENOL

Current Illness:

ID: 1508221
Sex: F
Age:
State: FL

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe stomach pain; Swollen glands; Vomiting; Severe headache; Severe fatigue; Knot in arm; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Mar2021 at 08:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia. It was unknown whether the patient had any allergies to medications, food, or other products. Concomitant medications included ziprasidone (MANUFACTURER UNKNOWN), clonazepam (MANUFACTURER UNKNOWN) and fluoxetine (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Mar2021 at 08:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, right after second dose, the patient experienced sore arm and knot in arm (muscle spasm). On 28Mar2021 at 20:00, two days after second dose, the patient experienced severe fatigue and severe headache. On 02Apr2021, one week after second dose, the patient experienced vomiting, severe stomach pain, swollen glands and severe fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse events. The clinical outcome of the event sore arm, knot in arm (muscle spasm), severe fatigue, severe headache, vomiting, severe stomach pain and swollen glands was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ZIPRASIDONE; CLONAZEPAM; FLUOXETINE

Current Illness:

ID: 1508222
Sex: F
Age:
State: WA

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tender lymph gland (near collarbone, on same side as vaccinated arm); swollen lymph gland (near collarbone, on same side as vaccinated arm); Nausea; Headache; diarrhea; General tiredness; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 10:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included statin (MANAFACTURER UNKNOWN) 40 mg, multi vitamin (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 the patient experienced tiredness, and on 01Apr2021 experienced nausea, headache, diarrhea, swollen lymph nodes, lymph node tenderness. It was reported that swollen and tender lymph gland near collarbone, on same side as vaccinated arm. Lymph gland was still swollen - 8 days later. The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Clinical outcome of tiredness, nausea, headache, diarrhea, swollen lymph nodes, lymph node tenderness was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508223
Sex: F
Age:
State:

Vax Date: 04/02/2021
Onset Date: 04/04/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Twitching; Muscle spasms near the shot site every few minutes; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8733) via an unspecified route of administration in the left arm on 02Apr2021 at 15:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease, anaemia, shellfish allergy, cockroach allergy and fruit allergy (allergy to tomatoes). Concomitant medications included sertraline hydrochloride (ZOLOFT), levothyroxine (MANUFACTURER UNKNOWN) and fexofenadine hydrochloride (ALLEGRA) all for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 12:00 the patient experienced twitching/muscle spasms near the shot site every few minutes. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event twitching and muscle spasms was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT; LEVOTHYROXINE; ALLEGRA

Current Illness:

ID: 1508224
Sex: M
Age:
State: MI

Vax Date: 03/24/2021
Onset Date: 03/26/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: High blood pressure; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration in the left arm on 24Mar2021 at 15:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and penicillin allergy. The patient received other medications(unspecified) within 2 weeks of COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 26Mar2021 on 12:00, the patient experienced high blood pressure. The treatment received for the reported event was unknown. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event high blood pressure was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508225
Sex: F
Age:
State: IA

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; Site soreness; Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 11:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history were reported as none. Concomitant medications included cetirizine hydrochloride (ZYRTEC), pseudoephedrine hydrochloride (SUDAFED), montelukast sodium (MONTELUKAST), sertraline (MANUFACTURER UNKNOWN) and norethisterone, ethinyl estradiol(NORTREL), all from an unknown date and for unspecified indication. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Apr2021 at 15:00, the patient experienced site soreness(vaccination site pain), headache, extreme nausea and dizziness which lasted about 36 hours. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event site soreness, headache, extreme nausea and dizziness was recovered on an unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Zyrtec; Sudafed; MONTELUKAST; SERTRALINE; Nortrel

Current Illness:

ID: 1508226
Sex: F
Age:
State: CA

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: period within 2 hours of the vaccination (not near the date where I was supposed to have my period); tired; feeling unwell; nausea; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm left on 15Mar2021 at 09:30 (at the age of 44-year-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm left on 05Apr2021 at 09:45 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to penicillin. The patient did not take any concomitant medication. The patient previously took Augmentin on unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021 at 11:30 within 2 hours of the vaccination, the patient experienced period (not near the date where she was supposed to have her period), tired, feeling unwell and nausea. The clinical outcome of the event period (not near the date where she was supposed to have her period), tired, feeling unwell and nausea was unknown. On 05Apr2021 at 11:30 within 2 hours of the vaccination, the patient experienced period (not near the date where she was supposed to have her period), tired, feeling unwell and nausea. The clinical outcomes of the events period within 2 hours of the vaccination, tired, feeling unwell and nausea were recovered on an unknown date in Apr2021. The patient did not receive treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508227
Sex: M
Age:
State: IL

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lymph node in left armpit tender; Swollen Lymph node in left armpit; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 03Apr2021 at 13:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 06Mar2021 at 13:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 at 21:30, the patient experienced swollen lymph node in left armpit, which was also tender for a limited time. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events of lymph node tenderness and axillary lymph nodes enlarged were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1508228
Sex: M
Age:
State: IL

Vax Date: 03/23/2021
Onset Date: 03/29/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy; Red, bumpy skin around upper body; noticeable itchy, red, bumpyskin around my upper body, especiallyleft and right sides of upper body,neck, chest.; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Mar2021 at 15:00(at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to cats, dusts and mite allergy. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), ascorbic acid (VITAMIN C), cannabidiol (CBD OIL) and THC, all from unknown dates and for unspecified indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 23Mar2021, the patient underwent PCR(nasal swab) test and the result was negative. On 29Mar2021 at 13:00 6th day of vaccination, the patient experienced itchy, red, bumpy skin(skin lesions NOS) around upper body especially left and right sides of upper body, neck, chest. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment for the reported events which included benadryl once in the evening on 29Mar2021 and the symptoms were gone and returned mindly on the 30Mar2021.The patient took claritin instead for two extra days and stopped, all symptoms were gone. The clinical outcome of the event itchy, red, bumpy skin around upper body was recovered on unspecified date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ADDERALL; Vitamin c; CBD OIL

Current Illness:

ID: 1508229
Sex: F
Age:
State: CA

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red bump at site of injection; Nausea; Headache; Tiredness; dark mark on my skin where the redbump was and it's been three weeks; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Mar2021 at 14:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. No relevant medical history. Concomitant medications included sertraline hydrochloride (ZOLOFT) and trazodone (MANUFACTURER UNKNOWN) started from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient not diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. On 15Mar2021 at 14:15 the patient experienced nausea, headache, tiredness and red bump at site of injection(vaccination site erythema). She also had a dark mark on her skin where the red bump(vaccination site lump) was and it had been three weeks. The patient did not receive any treatment for the events. The events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event nausea, headache, tiredness, red bump at site of injection and a dark mark on her skin where the red bump was recovered on unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds: ZOLOFT; TRAZODONE

Current Illness:

ID: 1508230
Sex: F
Age:
State: CT

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body chills, fever, stomachpain, nauseous, fatigue and headacheat various times for rest ofday/night/next day.; Body chills, fever, stomachpain, nauseous, fatigue and headacheat various times for rest ofday/night/next day.; Body chills, fever, stomachpain, nauseous, fatigue and headacheat various times for rest ofday/night/next day.; Body aches, chills, skin sensitivity fever, very bad headache with light sensitivity and trouble focusing eyes; Body aches, chills, skin sensitivity fever, very bad headache with light sensitivity and trouble focusing eyes; Body aches, chills, skin sensitivity, fever, very bad headache with light sensitivity and trouble focusing eyes; Body aches, chills, skin sensitivity, fever, very bad headache with light sensitivity and trouble focusing eyes; Body aches, chills, skin sensitivity, fever, very bad headache with light sensitivity and trouble focusing eyes; Body aches, chills, skin sensitivity, fever, very bad headache with light sensitivity and trouble focusing eyes; Body aches, chills, skin sensitivity, fever, very bad headache with light sensitivity and trouble focusing eyes; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EP6955) via an unspecified route of administration in the left arm on 01Apr2021 at 10:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included previous lobular carcinoma in-situ pronounced clear in Dec2020, environmental allergies and penicillin allergy. Concomitant medications included tamoxifen (MANUFACTURER UNKNOWN) for previous Lobular carcinoma in-situ; loratadine (MANUFACTURER UNKNOWN) and vitamin d nos (VIT D) (prescribed); for unknown indications and from unknown dates. The patient previously received erythromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EL3247) via an unspecified route of administration in the left arm on 11Mar2021 at 10:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 01Apr2021, 12 hours after vaccination the patient experienced body aches, chills, skin sensitivity, fever, very bad headache with light sensitivity and trouble focusing eyes from Thursday night to Friday night. On Saturday 03Apr2021 by 10:00, the patient felt better but had body chills, fever, stomach pain, nauseous, fatigue and headache at various times for the rest of the day/night and the next day. On Monday 05Apr2021, the patient felt somewhat better, slightly nauseous and fatigued. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the event body aches, chills, skin sensitivity, fever, headache, light sensitivity to eyes, difficulty focusing eyes, stomach pain, nausea and fatigue was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TAMOXIFEN; LORATADINE; Vit d

Current Illness:

ID: 1508231
Sex: F
Age:
State: CA

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; body aches; nausea; vomiting; headache; skin sensitivity; abdominal pain; pain in injection site; pain in neck on side of injection site; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm right on 01Apr2021 at 11:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included birth Control Pill, fexofenadine hydrochloride (ALLEGRA), paracetamol (TYLENOL), mefenamic acid (ADVIL). The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the arm right on 09Mar2021 at 14:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient previously took Codeine and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 03:15 the patient experienced chills, body aches, nausea, vomiting, headache, skin sensitivity, abdominal pain, pain in the injection site and pain in neck on side of injection site. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visits, and the emergency room/department or urgent care. The clinical outcome of the event chills, body aches, nausea, vomiting, headache, skin sensitivity, abdominal pain, pain in the injection site and pain in neck on side of the injection site was recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA; TYLENOL; Advil

Current Illness:

ID: 1508232
Sex: F
Age:
State: NC

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site pain; Tiredness; Headache; Muscle pain; Joint pain; Chills; Fever; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 03Apr2021 at 12:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, hypertension, prediabetes, anxiety, depression, attention deficit hyperactivity disorder (ADHD) and COVID-19. The patient had known allergies to dust, mold and cat dander. Concomitant medications included escitalopram (MANUFACTURER UNKNOWN), clonidine (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN) all taken from an unknown date for unknown indications. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 03Apr2021 at 20:00, the patient experienced injection site pain (vaccination site pain), tiredness, headache, muscle pain, joint pain, chills, fever and nausea. The events did not result in a doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events experienced. The clinical outcome of the events injection site pain (vaccination site pain), tiredness, headache, muscle pain, joint pain, chills, fever and nausea were resolving at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: ESCITALOPRAM; CLONIDINE; AMLODIPINE

Current Illness:

ID: 1508233
Sex: F
Age:
State: AZ

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe headache; nausea; fatigue; chills; body ache; 100 degree fever; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 02Apr2021 at 09:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression and pain pelvic. The patient was allergic to melon and bermuda grass. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included lithium (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN), lamotrigine (LAMICTAL) and levomefolic acid (METHYLFOLAT). The patient previously received PERCOCET for unknown indication and experienced drug allergy. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 15:00, the patient experienced severe headache, nausea, fatigue, chills, body aches and 100-degree fever. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events severe headache, nausea, fatigue, chills, body aches and 100-degree fever were resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: LITHIUM; SERTRALINE; LAMICTAL; METHYLFOLAT

Current Illness:

ID: 1508234
Sex: M
Age:
State: OH

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lightheaded and dizziness; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 05Apr2021 at 15:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included dysautonomia and POTS (postural orthostatic tachycardia syndrome); both from an unknown date. The patient did not have any allergies to medications, food, or other products. Concomitant medications included nadolol (MANUFACTURER UNKNOWN), ciclosporin (RESTASIS), magnesium (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D) and ubidecarenone (COQ); all from an unknown date for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 15:15, the patient experienced lightheaded and dizziness and brain fog. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events lightheaded and dizziness and brain fog was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NADOLOL; RESTASIS; MAGNESIUM; Vitamin c; Vitamin d; COQ

Current Illness:

ID: 1508235
Sex: F
Age:
State: MT

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm at shot location; Pins and needles sensation upper body; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the arm left on 04Feb2021 at 13:00(at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Feb2021 the patient experienced sore arm at shot location and pins and needles sensation upper body. Sore arm was still present 10 weeks after the shot at the shot location and pins and needles sensation in upper body off and on still. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events sore arm and pins and needles sensation upper body was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508236
Sex: F
Age:
State: MN

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever of 101; Feel crappy; Tired; Seeing spots; Pulse up to 120; B/p was 160; Light headed; Tingly; This is a spontaneous report from a contactable nurse, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 11:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and known allergies as blotchy and sensitive skin. Concomitant medications included cetirizine hydrochloride (ZYRTEC) 1 per day, 2000 units of colecalciferol (VITAMIN D3) and 500mg of ascorbic acid (VITAMIN C); all from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021, 10minutes after the shot, the patient was driving and started seeing spots, pulse was up to 120, blood pressure was 160 at the fire station. Light headed and tingly. Done in 3 hours and left ED. Next day (25Mar2021), the patient experienced just tired. On day 5, (29Mar2021), the patient experienced fever of 101 and felt crappy. The patient took ibuprofen. The patient would talk to an allergist before taking the second one. Her risk factor was obesity BMI of 40. The events seeing spots, pulse was up to 120, blood pressure was 160, light headed and tingly resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of fever of 101, felt crappy and included treatment with ibuprofen (MANUFACTURER UNKNOWN). The clinical outcomes of spots, pulse up to 120, blood pressure was 160, light headed, tingly were recovered with sequelae on 24Mar2021. The clinical outcomes of tiredness, fever of 101, felt crappy were recovered with sequelae on an unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Zyrtec; VITAMIN D3; Vitamin c

Current Illness:

ID: 1508237
Sex: M
Age:
State: NC

Vax Date: 03/20/2021
Onset Date: 03/23/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sensory neuropathy; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 20Mar2021 at 14:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included peripheral sensory neuropathy. The patient did not have any allergies to food, medications, or other products. Concomitant medications included regular duloxetine (MANUFACTURER UNKNOWN) 30mg and rosuvastatin calcium (CRESTOR) 10mg. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 13:00 the patient experienced sensory neuropathy. It was reported that the patient had a minor sensory neuropathy at the lower extremes before the shot and it clearly flared up after the first shot. It seemed to be better at the time of this report. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event sensory neuropathy was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: DULOXETINE; CRESTOR

Current Illness:

ID: 1508238
Sex: F
Age:
State: NY

Vax Date: 04/01/2021
Onset Date: 04/03/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pins and needles/tingling in right fingers; Numbness in right fingers; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 01Apr2021 at 13:15 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included liposarcoma (cancer) in right leg in 2007, radiation and surgery to treat liposarcoma in 2007 and preeclampsia during pregnancy in 2017. The patient was allergic to penicillin. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), prenatal vitamin, probiotic and calcium (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 00:00, the patient experienced needles/tingling/numbness in her right fingers. It was in her middle finger, ring finger and pinkie finger. It went between the entire finger and from the middle knuckle up to the tip. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of the events pins and needles/tingling in right fingers and numbness in right fingers were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D NOS; CALCIUM

Current Illness:

ID: 1508239
Sex: F
Age:
State: PA

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: One hour after the shot I had hives from the shot site to my wrist, stomach, and hives on my ankles.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 18:45 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date. The patient previously received Ibuprofen (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 03Apr2021 at 19:45, one hour after the vaccination, the patient experienced hives from the shot site to her wrist, stomach, and hives on her ankles, that lasted for 4 hours. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event hives from the shot site to her wrist, stomach, and hives on her ankles was recovered on 03Apr2021 at 23:45. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LISINOPRIL

Current Illness:

ID: 1508240
Sex: F
Age:
State: WI

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness in injection site muscle; significant fatigue; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Mar2021(at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma (predisposition to walking pneumonia). The patient did not have any allergies to medications, food, or other products. Concomitant medications included naproxen sodium (ALEVE) which was taken 1 week prior, on an unknown date and for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 the patient experienced soreness in injection site muscle (vaccination site pain) and significant fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse event. The clinical outcome of the event soreness in injection site muscle (vaccination site pain) and significant fatigue was recovered on an unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ALEVE

Current Illness:

ID: 1508241
Sex: F
Age:
State: NY

Vax Date: 03/28/2021
Onset Date: 04/01/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen lymph node on left collar bone.; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8727) via an unspecified route of administration in the left arm on 28Mar2021 at 15:45 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no allergies to medications, food, or other products. On 01Apr2021 at 08:00, the patient experienced swollen lymph node on her left collar bone. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event swollen lymph node on left collar bone was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508242
Sex: M
Age:
State: IL

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; tiredness; joint aches; left side of face tingle; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 01Apr2021 at 16:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had intermittent shellfish allergies and only certain shellfish trigger allergic reactions but it's very rare. Concomitant medications included famotidine (MANUFACTURER UNKNOWN) 20 mg taken once daily from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 10:00 the patient experienced chills, tiredness, joint aches and left side of face tingle. The events did not result in doctor or other health care professional office/clinic visits, and the emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events chills, tiredness, joint aches and left side of face tingle were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: FAMOTIDINE

Current Illness:

ID: 1508243
Sex: F
Age:
State: MA

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732), via an unspecified route of administration in the arm left on 31Mar2021 at 13:00 (at the age of 68-year-old), as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy (sulfa drugs). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the arm left on 10Mar2021 (at the age of 68-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced flu-like symptoms and sore arm (reported as starting day 2 and ending on day 3). On 04Apr2021 at 12:00, the patient experienced feel very, very itchy on the skin behind ears, on neck, stomach and thighs, too itchy to sleep at night. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sore arm, flu-like symptoms and feel very, very itchy on the skin behind ears, on neck, stomach and thighs was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508244
Sex: F
Age:
State: TX

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Slight confusion; Slight dizziness; Itching; Redness of skin; Some numbness of throat; Tingling lips; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the arm right on 05Apr2021 at 14:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown whether the patient had any known allergies to medications, food or other products. Concomitant medications included vitamin D nos (VITAMIN D) 50,000 IU, levothyroxine (MANUFACTURER UNKNOWN) 100 mg and vitamin E nos (VITAMIN E) all for an unknown indications, from an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 14:30 the patient experienced slight confusion which abated within first 5 minutes after injection, slight dizziness, itching, redness of skin, some numbness of throat and tingling lips. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of reported events. The clinical outcome of the event slight confusion which abated within first 5 minutes after injection i.e. 05Apr2021 at 14:35, slight dizziness, itching, redness of skin, some numbness of throat and tingling lips was recovered on 05Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Vitamin d; LEVOTHYROXINE; Vitamin e

Current Illness:

ID: 1508245
Sex: F
Age:
State: NM

Vax Date: 03/25/2021
Onset Date: 03/28/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 25Mar2021 at 10:00 as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, slow heart beat and heart palpitations. The patient had no known allergies to medications, food or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) of 100mg, magnesium (MANUFACTURER UNKNOWN) and ascorbic acid, tocopheryl acetate, zinc, xantofyl, zeaxanthin (AREDS); all from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021 at 12:00, the patient experienced tinnitus. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of tinnitus was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; MAGNESIUM; AREDS

Current Illness:

ID: 1508246
Sex: F
Age:
State: CA

Vax Date: 03/22/2021
Onset Date:
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lots of back pain; Fever of 99 F; Severe arm soreness at injection location; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EU6207), via an unspecified route of administration in the left arm on 22Mar2021 at 13:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included inflammatory arthritis. Concomitant medications included sulfasalazine (SULFASALAZINE), methotrexate (METHOTREXATE), meloxicam (MELOXICAM) and folic acid (FOLIC ACID) all taken from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in 2021, the patient experienced a fever of 99-degree Fahrenheit for 4 hours, severe arm soreness at injection location (vaccination site pain), lots of back pain and fatigue. The events did not result in a doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events experienced. The clinical outcome of the events lots of back pain, fever of 99-degree Fahrenheit, severe arm soreness at injection location (vaccination site pain) and fatigue was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SULFASALAZINE; METHOTREXATE; MELOXICAM; FOLIC ACID

Current Illness:

ID: 1508247
Sex: M
Age:
State: NH

Vax Date: 03/23/2021
Onset Date: 03/26/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe joint pain in toes; Numbness of feet; swelling of the foot and ankle both feet are affected the left foot is the worst; swelling of the foot and ankle both feet are affected the left foot is the worst; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 09:30 (at the age of 73-year-old) as single dose for COVID-19 immunisation. Medical history included coronary heart disease. The patient received unspecified medication within two weeks, Prior to vaccination. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccination within 4 weeks prior to the COVID vaccine. On 26Mar2021 at 15:45, the patient experienced severe joint pain in toes, numbness of feet and swelling of the foot and ankle both feet were affected the left foot was the worst. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported event. The clinical outcome of the events severe joint pain in toes, numbness of feet, swelling of the foot and ankle both feet are affected the left foot is the worst were not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508248
Sex: M
Age:
State: GA

Vax Date: 04/04/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Still experiencing severe muscle pain in right leg and left arm (arm was vax site); Severe migraine; Flu-like symptoms; Diarrhea; Nausea; Temperature regulation issues; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 7533) via an unspecified route of administration in the left arm on 04Apr2021 at 17:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Information on medical history and known allergies was not available. Information on whether the patient had received any other medications in two weeks was not available. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6203) via an unspecified route of administration in the left arm on 13Mar2021 at 13:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 08:00 the patient was still experiencing severe muscle pain in his right leg and left arm (arm was vax site), severe migraine, flu-like symptoms, diarrhea, nausea, and temperature regulation issues. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events severe muscle pain in right leg and left arm (arm was vax site), severe migraine, flu-like symptoms, diarrhea, nausea, and temperature regulation issues was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508249
Sex: F
Age:
State: TX

Vax Date: 03/23/2021
Onset Date: 03/31/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red rash with bumps and some small blisters on right side of face near lips, chin left side, up across the left cheek, left ear, and part of the neck; Feels slight burning; Itch; Left ear lope got very swollen; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: EN6204) via an unspecified route of administration in the right arm on 23Mar2021 at 12:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and allergies to medications, food, or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), testosterone (MANUFACTURER UNKNOWN) sustained-release and estradiol, estriol (BI EST), all for unknown indications from unknown dates. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021, the patient had rash on face, that started on right side near lips and spread to the chin to the left side and up across the left cheek and to the left ear and then part of the neck. The rash was red with bumps and some small blisters. The patient felt slight burning and itch. The patient had very swollen left ear lope. The events lasted for 6 or more days. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events red rash with bumps and some small blisters on right side of face near lips, chin left side, up across the left cheek, left ear, and part of the neck, felt slight burning, itch and left ear lope got very swollen were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; TESTOSTERONE; BI EST

Current Illness:

ID: 1508250
Sex: F
Age:
State: OH

Vax Date: 03/28/2021
Onset Date: 03/29/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching around wrists, under breasts, armpits, in between legs, and back of legs; hair and head, and wrists started itching.; Itching around wrists, under breasts, armpits, in between legs, and back of legs, then it turned into hives; hives all over body; Severe heartburn; Pressure in chest; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the arm left on 28Mar2021 at 08:30 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included hives. The patient had no allergies to medications, food, or other products. Concomitant medications included ibuprofen (ADVIL) reportedly might have taken 1 or 2 in the 2 weeks prior vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 11:00 hours, one day after the vaccination, the patient began noticing itching around wrists, under breasts, armpits, in between legs, and back of legs, then it turned into hives. On the same day, the patient also felt severe heartburn, but took TUMS and it went away. The patient was not sure if it was related to vaccination but felt like pressure in chest. The hives and itching went away at night but came back on 30Mar2021. The itching and hives continued for 4 days, again went away at night then back the next day, the hives were all over body. The patient had hives before, but were not like this. The patient took a over the counter (OTC) medication ZYRTEC on day 5, hives and itching completely stopped. Then on 05Apr2021, one week and one day after vaccine, patient's hair and head and wrists started itching. The hives and itching were back, but not as bad this time, and patient took a ZYRTEC right away to prevent hives and itching, which seemed like it was working. The adverse events neither resulted in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. The patient also received treatment for pressure in chest. The clinical outcomes of the events severe heartburn, pressure in chest, itching around wrists, under breasts, armpits, in between legs, and back of legs which turned to hives, hair and head and wrists started itching and hives all over body were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds: Advil

Current Illness:

ID: 1508251
Sex: F
Age:
State: NC

Vax Date: 01/09/2021
Onset Date: 03/25/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Numbness in hands and feet; Tingling in hands and feet; Pain in hands; Redness in hands; Swelling in hands; This is a spontaneous report from a contactable other healthcare professional, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an intramuscular route of administration in the left arm on 09Jan2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. No relevant medical history was reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included duloxetine hydrochloride (CYMBALTA) taken from an unknown date for an unknown indication and birth control pill (MANUFACTURER UNKNOWN) taken from an unknown date. The patient had no allergies to medications, food, or other products. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an intramuscular route of administration in the left arm on 19Dec2020 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 25Mar2021 at 13:00 the patient experienced numbness and tingling in hands and feet 3 months later. The patient also experienced pain in hands, redness in hands and swelling in hands on 25Mar2021 at 13:00. The adverse events resulted in a visit to the doctor or other healthcare professional office/clinic visit. Therapeutic measures included intake of naproxen for the reported events. The clinical outcome of the events numbness and tingling in hands and feet, pain in hands, redness in hands and swelling in hands were not resolved at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: CYMBALTA

Current Illness:

ID: 1508252
Sex: F
Age:
State: OH

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 13:15 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 01:00 the patient experienced pins and needles in her fingers and her hands. When she woke up on 03Apr2021 the problem persisted, and she also began to feel weakness and numbness in her hands. It was difficult to grip things, and at night she began to feel pins and needles in her feet, arms, and shoulders. On 04Apr2021 the problem still persisted, although she felt less of a tingling sensation in her shoulders. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event pins and needles in fingers and hands/pins and needles in feet, arms and shoulders/tingling sensation in shoulders, weakness in hands, numbness in hands and difficulty to grip things was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1508253
Sex: F
Age:
State: OR

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in all joints in my left arm started about 1-2 hours after receiving injection. Joints: Shoulder, elbow, wrist and hands. Obviously pain in the muscle where I received the injection but thats exp; pain in the muscle where I received the injection; This is a spontaneous report from a contactable nurse, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via intramuscular route of administration in the left arm on 05Apr2021 (At the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 11:00 the patient experienced pain in all joints in left arm started about 1-2 hours after receiving injection. Joints: Shoulder, elbow, wrist and hands. Obviously pain in the muscle where she received the injection but that was expected with any intramuscular injection. Patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events joint pain, muscle pain was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508254
Sex: M
Age:
State: OH

Vax Date: 04/04/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Abdominal pain; Diarrhea; Nose bleeds that took a long time to stop and that were quite heavy; Intense nausea; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via unspecified route of administration in the left arm on 04Apr2021 at 13:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, functional dyspepsia, anxiety, depression, obsessive-compulsive disorder (OCD) and emetophobia. The patient was allergic to tree nuts. Concomitant medications included amitriptyline (MANUFACTURER UNKNOWN) on an unknown date and for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 11:30, 24 hours after the vaccination, patient had diarrhea and further experienced multiple nose bleeds that took a long time to stop and were quite heavy, intense nausea and abdominal pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events multiple nose bleeds, intense nausea, abdominal pain and diarrhea were resolving at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: AMITRIPTYLINE

Current Illness:

ID: 1508255
Sex: F
Age:
State: LA

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore throat; Muscle aches; Joint pain; Febrile; Swollen lymph node in armpit; Cough; This is a spontaneous report from a contactable other healthcare professional, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 25Mar2021 at 15:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was allergic to penicillin, ibuprofen, bactrim and propofol. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 16:30, after 1485 minutes of the vaccination, the patient experienced sore throat, muscle aches, joint pain, febrile, swollen lymph node in armpit of arm shot was given in and cough. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sore throat, muscle aches, joint pain, febrile, swollen lymph node in armpit and cough was resolved on an unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508256
Sex: F
Age:
State: NY

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lightheaded; extreme stomach pains; low grade fever; chills; body aches; full blown nausea; dizziness; This is a spontaneous report from a contactable other healthcare professional, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 27Mar2021(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and penicillin allergy. Concomitant medications included olmesartan (MANUFACTURER UNKNOWN) and chlortalidone (CHLORTHALIDONE) all from an unknown date for unspecified indication. The patient previously took first dose of BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 06Mar2021 at 10:15 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 02:00, the patient experienced low grade fever, chills, body aches. Woke up from sleep with full blown nausea, dizziness, lightheaded with extreme stomach pains. Symptoms have continued for the last 8 days since getting second vaccine. Visited medical provider on 05Apr2021. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported events and included treatment with meclizine 12.5 mg / blood work. The clinical outcome of the events low grade fever, chills, body aches, full blown nausea, dizziness, lightheaded and extreme stomach pains was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: OLMESARTAN; CHLORTHALIDONE

Current Illness:

ID: 1508257
Sex: F
Age:
State: SC

Vax Date: 04/04/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever 99.5; Chills; Vomiting; Nausea; Pain at injection site; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 04Apr2021 at 14:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic kidney disease stage 3 (Ckd stage 3), non-alcoholic fatty liver, tachycardia, adrenal insufficiency from unilateral adrenalectomy. The patient had previously taken penicillin and experienced penicillin allergy. Concomitant medications taken within two weeks prior to vaccination included lisinopril (MANUFACTURER UNKNOWN), carvedilol (COREG), montelukast sodium (SINGULAIR), hydrochlorothiazide (MANUFACTURER UNKNOWN), omeprazole (PROZA), all for unknown indication from unknown date. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 14Mar2021 at 14:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 15:00, the patient experienced fever 99.5 (unspecified units), chills, vomiting, nausea, pain at injection site and body aches. Therapeutic measures were taken as a result of nausea for which the doctor called in antinausea medication. The adverse events fever 99.5 (unspecified units), chills, vomiting, pain at injection site and body aches did not result in doctor or other healthcare professional office/clinic visit/emergency visit. The clinical outcome of the events fever 99.5, chills, vomiting, nausea, pain at injection site and body aches was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; COREG; SINGULAIR; HYDROCHLOROTHIAZIDE; PROZA

Current Illness:

ID: 1508258
Sex: F
Age:
State: FL

Vax Date: 03/30/2021
Onset Date: 04/04/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe congestion; Fever; Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EX16205) via an unspecified route of administration in the left arm on 30Mar2021 at 08:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included hypothyroidism. The patient did not have any allergies to food, medications, or other products. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) 75 mcg from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 13:00, the patient experienced severe congestion, sore throat and fever. Patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events congestion, fever and sore throat was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1508259
Sex: F
Age:
State: FL

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mild allergic reaction; Itching at injection site; Itching throughout the body; body aches; Chills; fatigue; Slight metallic taste; Numbing sensation on tongue; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 02Apr2021 at 11:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (HBP), diabetes, non-alcoholic steatohepatitis (NASH), overweight and COVID-19. Concomitant medications included telmisartan (MANUFACTURER UNKNOWN), atenolol (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), cetirizine hydrochloride (CETRIZINE) and folic acid (MANUFACTURER UNKNOWN) all for unspecified indication started from an unknown date. The patient previously took fenofibrate (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously took prednisone (MANUFACTURER UNKNOWN) and experienced strong reaction (unspecified) to methyl-prednisone. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, minutes after the vaccination, the patient experienced slight metallic taste and numbing sensation on tongue. On 03Apr2021, the patient experienced body aches, chills, fatigue. On 04Apr2021 at 16:00, the patient experienced mild allergic reaction and itching at injection and itching throughout the body. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event metallic taste and numbing sensation on tongue was recovered on 02Apr2021 ; while that of body aches, chills and fatigue was recovered on an unknown date in Apr2021. The clinical outcome of events itching at injection site, itching throughout the body was recovering; while that of mild allergic reaction was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: TELMISARTAN; ATENOLOL; METFORMIN; CETRIZINE; FOLIC ACID

Current Illness:

ID: 1508260
Sex: F
Age:
State: CA

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme nausea; Vomiting; Stomach pain; Ringing in ears; Fever; Extreme muscle fatigue; Still sick; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 08:15 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 15:00, the patient experienced extreme nausea, vomiting, stomach pain, ringing in ears, fever, extreme muscle fatigue and still sick 5 days later. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcomes of the events extreme nausea, vomiting, stomach pain, ringing in ears, fever, extreme muscle fatigue and still sick 5 days later were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508261
Sex: F
Age:
State: CA

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Metallic taste; heightened dizziness; Stomach upset; pain; exhaustion; headache; This is a spontaneous report from a contactable consumer. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 05Apr2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, benign essential tremor, osteoarthritis. The patient previously received codeine phosphate (CODEINE) for unknown indication on an unknown date and experienced drug allergy. It was unknown if the patient was diagnosed with COVID-19, prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), fluoxetine hydrochloride (PROZAC), curcuma longa root (TURMERIC) and paracetamol (TYLENOL) started from unknown date for unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 13:00 the patient experienced metallic taste, heightened dizziness, stomach upset, pain, exhaustion and headache. The adverse events had not resulted in a visit to the doctors or other healthcare professional office or clinic visit or emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events metallic taste, heightened dizziness, stomach upset, pain, exhaustion and headache was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: MELOXICAM; OMEPRAZOLE; PROZAC; Turmeric; TYLENOL

Current Illness:

ID: 1508262
Sex: F
Age:
State: AZ

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Incessant sneezing; Swelling in face; Sinus congestion; Hives around patient body; Extreme nausea; Body aches; Fever of up to 102; Headache; This is a spontaneous report from a contactable consumer, the patient. A 30-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 31Mar2021 at 12:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medication within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 31Mar2021 at 18:00, the patient experienced fever of up to 102 (body temperature was 102(unspecified units)), body aches, headache and extreme nausea (incapable of holding down everything including water). On 04Apr2021, the patient experienced incessant sneezing, swelling in face, sinus congestion and hives around body. No therapeutic measures were taken as a result of reported events. The clinical outcome of fever of up to 102, body aches, headache and extreme nausea was not recovered. The clinical outcome of the swelling in face and hives around body was lasting about 12 hours i.e. recovered on an unspecified time on 04Apr2021; while that of incessant sneezing and sinus congestion was recovered on 05Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508263
Sex: F
Age:
State: CO

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Woke up and my lips werecompletely swollen, I have had fillersin the past. Very painful experience forme; Fevers; Tons of pain; I was very sick the first night; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 03Apr2021 at 08:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergy to nuts (allergic to cashews and pistachios) and COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), fish oil (MANUFACTURER UNKNOWN) and b vitamins (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 16:00, the patient was very sick the first night, fevers with tons of pain. On 05Apr2021, on Monday morning, the patient woke up and lips were completely swollen, the patient had fillers in the past and had a very painful experience. The events resulted in doctor or other healthcare professional office or clinic visit. Therapeutic measures were taken as a result of events and included treatment with benadryl and steroid. The clinical outcome of the events pain, sickness, swollen lips and fevers were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ADDERALL; FISH OIL

Current Illness:

ID: 1508264
Sex: M
Age:
State: AZ

Vax Date: 03/21/2021
Onset Date: 03/23/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tinnitus, high pitch frequency sound inboth ears; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old, male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route in left arm on 21Mar2021 (at an age of 66-years-old) as single dose for COVID-19 immunisation. The medical history of patient was reported as none. The patient had no allergies to medications, food, or other products.The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route in left arm on 20Feb2021 (at the age of 66-years-old) as single dose for COVID-19 immunisation. The patient received citalopram (MANUFACTURERS UNKNOWN) and simvastatin (MANUFACTURERS UNKNOWN) started on an unknown date within 2 weeks prior to the COVID vaccine for unknown indications. Prior to the vaccination the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccination within 4 weeks prior to the COVID vaccine. On 23Mar2021, the patient had tinnitus, high pitch frequency sound in both ears. No treatment was given for the event. The clinical outcome of the event was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: CITALOPRAM; SIMVASTATIN

Current Illness:

ID: 1508265
Sex: M
Age:
State: PA

Vax Date: 03/25/2021
Onset Date: 03/28/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash break out on both forearms, just above and below both knees in the back of both leg; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021(at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 from unknown date. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), furosemide (MANUFACTURER UNKNOWN), tizanidine (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN) and ga (as reported); all for unspecified indication and from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021, the patient experienced rash break out on both forearms, just above and below both knees in the back of both legs. The patient underwent lab tests and procedures which included polymerase chain reaction test on 30Mar2021 and tested negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the event rash on legs and arm was not recovered at the time of reporting. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LISINOPRIL; FUROSEMIDE; TIZANIDINE; ATORVASTATIN

Current Illness:

ID: 1508266
Sex: M
Age:
State: MA

Vax Date: 04/04/2021
Onset Date: 04/04/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Slightly reduced range of motion in arm.; Slight soreness in vaccinated arm; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep7533), via an unspecified route of administration in the right arm on 04Apr2021 at 12:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history and other allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 18:30, the patient experienced slight soreness in vaccinated arm and slightly reduced range of motion in arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events slight soreness in vaccinated arm and slightly reduced range of motion in arm were recovered on an unspecified date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508267
Sex: M
Age:
State: WI

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe headache; nausea; chills; body aches; body aches/joint pain; dizziness; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWo150) via an unspecified route of administration in the left arm on 02Apr2021 at 14:45 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome (IBS). The patient received unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 06Mar2021 at 12:30 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies to medications, food or other products. On 03Apr2021, side effects took place approximately 12 hours after injection at 03:00, the patient experienced severe headache, nausea, chills, body aches/joint pain and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of severe headache, nausea, chills, body aches/joint pain and dizziness and included treatment with acetaminophen, 1000mg every 12 hours for 36 hours. The clinical outcome of the events headache, nausea, chills, body aches/joint pain and dizziness was recovered on an unknown date of Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508268
Sex: M
Age:
State: PA

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: significant discomfort in the injection area; soreness injection site; This is a spontaneous report from a contactable consumer. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 10:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included hyperthyroidism and blood pressure high. Patient previously received sulfamethoxazole for an unknown indication on an unknown date and experienced drug allergy. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), SYNTHROID, ezetimibe (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN), all for unknown indications from an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient underwent nasal swab test and the result was negative. On 20Mar2021, the patient experienced vaccination site discomfort and vaccination site soreness. Its reported that approximately 24 hours after the initial vaccine was administered patient experienced significant discomfort in the injection area that had been increasingly worse and sustained since the administration date with no improvement in discomfort and soreness. The events resulted in doctor or other healthcare professional office/clinic visit (discussed with pcp). The clinical outcome of the events of vaccination site discomfort and vaccination site pain were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LISINOPRIL; SYNTHROID; EZETIMIBE; MELATONIN

Current Illness:

ID: 1508269
Sex: F
Age:
State: IL

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Kidney pain; Jaw lymph nodes swelling; Jaw lymph nodes pain; Fatigue; Injection arm pain; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 10:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetic, asthma, high bp (blood pressure high), obese (obesity), arthritis and disc problems. The patient received many unspecified medications within two weeks of vaccination. The patient previously took sulfa (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy on unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 12:00 the patient experienced kidney pain, jaw lymph nodes swelling (swollen lymph nodes) and pain (lymph nodes pain), fatigue and injection arm pain (pain in arm). The patient did not receive any treatment for the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events kidney pain, jaw lymph nodes swelling, jaw lymph nodes pain, fatigue and injection arm pain were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm